ALFA FinderBSE filing, NSE: PARMAX. Summary written from the filing by ALFA Finder's alert engine.
Parmax Pharma Ltd: key numbers
- Share price
- ₹133.70
- Market cap
- ₹50.02 Cr
- Revenue (annual)
- ₹12.11 Cr
- Net profit (annual)
- ₹-4.16 Cr
- P/E (TTM)
- -41.9×Sector 43.0×
- Promoter holding
- 64.66%+33.86% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Parmax Pharma Ltd
All →Parmax Pharma Management Change
Parmax Pharma's independent director Ami Shah resigned effective October 28, 2026. The exit follows a change in management and control of the company.
Parmax Pharma Other Announcement
Parmax Pharma Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as required by SEBI regulations.
Parmax Pharma Management Change
Parmax Pharma Ltd announced the resignation of Mr. Nikhil Uchat as an Independent Director of the Company, effective October 08, 2026.
Parmax Pharma Annual General Meeting
Parmax Pharma Ltd conducted its 32nd Annual General Meeting on September 29, 2026, covering routine business including financial statement adoption and board appointments.
Parmax Pharma Adverse Business Impact
Parmax Pharma reported a major fire incident at its Rajkot plant on September 28, 2026. Two employees were injured, and the company is currently assessing the financial damage.
Parmax Pharma Other Announcement
Parmax Pharma Ltd filed its quarterly shareholding pattern under Regulation 31. The disclosure reflects changes in promoter status following a previously concluded open offer.
Other promoter reclassification announcements
All →Umiya Tubes Promoter Reclassification
Umiya Tubes received reclassification requests from two promoter group members to move to public category. Both hold nil shares and seek approval under Regulation 31A.
Baba Arts Promoter Reclassification
Baba Arts' board noted promoters Gordhan and Rahul Tanwani's request to reclassify as public shareholders. Company Secretary Naishadh Mankad resigned and Shilpi Shukla was appointed.
Vaxtex Cotfab Promoter Reclassification
Vaxtex Cotfab received NSE approval to reclassify Bharti Kailash Gupta, holding 0.40%, from promoter group to public. The change took effect on 5 November 2026.
Shri Gang Industries and Allied Products Promoter Reclassification
Shri Gang Industries received BSE no-objection for reclassifying four Gupta family members from promoter to public category under Regulation 31A. Shareholder approval is still required, and no monetary value is involved.
Olympic Management & Financial Services Promoter Reclassification
Olympic Management & Financial Services received BSE no-objection to reclassify Excel Paints Private Limited from promoter to public category under Regulation 31A. No shares or money changed hands.
EMA India Promoter Reclassification
EMA India submitted minutes of a postal ballot completed on 8 October 2026. Members approved reclassifying 38,000 shares (3.78%) from promoter to public category under Regulation 31A.